SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-035420
Filing Date
2020-03-18
Accepted
2020-03-18 16:42:15
Documents
3
Period of Report
2020-03-13
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2013080d1_8k.htm 8-K 24810
2 EXHIBIT 16.1 tm2013080d1_ex16-1.htm EX-16.1 3417
3 GRAPHIC tm2013080d1_ex16-1ing001.jpg GRAPHIC 2562
  Complete submission text file 0001104659-20-035420.txt   33241
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 20725111
SIC: 2834 Pharmaceutical Preparations